- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02708251
Glyceryl Trinitrate Versus Lidocaine Cream for IUD Insertion (GTN-IUD)
July 11, 2017 updated by: Ahmed Mohamed Abbas, Assiut University
Topical Glyceryl Trinitrate Versus Lidocaine Cream as Analgesia for IUD Insertion: A Randomized Controlled Trial
The intrauterine device (IUD) is a long-acting, highly effective, reversible contraceptive method that may be underutilized due to fear of pain during insertion.
Although providers frequently prescribe non-steroidal anti-inflammatory drugs (NSAIDs) for IUD insertion, there is no evidence for any pain reduction.
Women can experience high levels of pain when the IUD is placed inside the uterus, and fear of this pain could be a reason that women decide not to use this method.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
150
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Cairo
-
Assiut, Cairo, Egypt, 002
- Ahmed Abbas
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 49 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion criteria:
- Women not taken analgesics or anxiolytics in the 24 hours prior insertion
- Women not taken misoprostol prior to IUD insertion
- No contraindication to or history of allergic reaction to lidocaine or NO donors.
- Women who will accept to participate in the study
Exclusion criteria:
- Lidocaine allergy
- History of migraine or chronic headache
- Any contraindication to IUD placement
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: glyceryl trinitrate cream
The clinician will perform a bimanual examination, place the speculum, and cleanse the cervix with Betadine. 1 mL glyceryl trinitrate cream will be placed on the cervix at the anterior lip and 1 mL in the cervix up to the level of the internal os using cotton swab.
|
|
|
EXPERIMENTAL: lidocaine cream
The clinician will perform a bimanual examination, place the speculum, and cleanse the cervix with Betadine. 1 mL lidocaine creamwill be placed on the cervix at the anterior lip and 1 mL in the cervix up to the level of the internal os using cotton swab.
|
|
|
PLACEBO_COMPARATOR: placebo cream
The clinician will perform a bimanual examination, place the speculum, and cleanse the cervix with Betadine.1 mL placebo cream will be placed on the cervix at the anterior lip and 1 mL in the cervix up to the level of the internal os using cotton swab.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mean pain score during IUD insertion
Time Frame: 3 minutes
|
3 minutes
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Patient satisfaction score after the procedure
Time Frame: 3 minutes
|
3 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 1, 2016
Primary Completion (ACTUAL)
May 1, 2017
Study Completion (ACTUAL)
June 1, 2017
Study Registration Dates
First Submitted
March 10, 2016
First Submitted That Met QC Criteria
March 10, 2016
First Posted (ESTIMATE)
March 15, 2016
Study Record Updates
Last Update Posted (ACTUAL)
July 13, 2017
Last Update Submitted That Met QC Criteria
July 11, 2017
Last Verified
July 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Anti-Arrhythmia Agents
- Vasodilator Agents
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Membrane Transport Modulators
- Anesthetics, Local
- Voltage-Gated Sodium Channel Blockers
- Sodium Channel Blockers
- Lidocaine
- Nitroglycerin
Other Study ID Numbers
- GTN
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on IUD Insertion
-
Ain Shams UniversityCompleted
-
University of California, DavisCompleted
-
University of Missouri-ColumbiaTerminated
-
Thomas Jefferson UniversityTerminated
-
University of SaskatchewanCompletedIUD Insertion ComplicationCanada
-
Ain Shams UniversityUnknownIUD Insertion ComplicationEgypt
-
The University of Texas Health Science Center,...CompletedAnalgesia | IUD InsertionUnited States
-
Ain Shams UniversityRecruiting
-
Aspivix SACompleted
Clinical Trials on placebo cream
-
Sixera PharmaCompletedNetherton SyndromeFrance, Sweden, Austria, Germany
-
AstraZenecaFougera Pharmaceuticals Inc.Withdrawn
-
Medical University of LodzCompleted
-
AstraZenecaFougera Pharmaceuticals Inc.Withdrawn
-
University of North Carolina, CharlotteTeva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States
-
Santalis Pharmaceuticals, Inc.ClinDatrix, Inc.; Fremantle DermatologyWithdrawn
-
Dr.dr.Irma Bernadette, SpKK (K)Recruiting
-
Higher School of Applied Sciences (VIST)Abies Labs d.o.o.CompletedSkin Care | Wrinkles | Ageing | Photoprotection | Skin Cream
-
Rock Creek Pharmaceuticals, Inc.CompletedRosaceaUnited States
-
Revotar Biopharmaceuticals AGCompleted